109 related articles for article (PubMed ID: 11305042)
1. [Assessment of anti-tremorogenic drugs using nicotine-induced tail-tremor model and elucidation of the mechanism].
Suemaru K; Araki H; Gomita Y
Yakugaku Zasshi; 2001 Apr; 121(4):259-64. PubMed ID: 11305042
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model].
Suemaru K; Kawasaki H; Gomita Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):123-7. PubMed ID: 9278937
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide in development of tail-tremor induced by repeated nicotine administration in rats.
Suemaru K; Kawasaki H; Gomita Y; Tanizaki Y
Eur J Pharmacol; 1997 Sep; 335(2-3):139-43. PubMed ID: 9369366
[TBL] [Abstract][Full Text] [Related]
4. Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Suemaru K; Kawasaki H; Oishi R; Gomita Y; Tanizaki Y
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):571-5. PubMed ID: 9151294
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
Suemaru K; Gomita Y; Furuno K; Araki Y
Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of tail-tremor induced by nicotine in rats.
Suemaru K; Oishi R; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):153-7. PubMed ID: 7990972
[TBL] [Abstract][Full Text] [Related]
7. Nicotine evokes kinetic tremor by activating the inferior olive via α7 nicotinic acetylcholine receptors.
Kunisawa N; Iha HA; Shimizu S; Tokudome K; Mukai T; Kinboshi M; Serikawa T; Ohno Y
Behav Brain Res; 2016 Nov; 314():173-80. PubMed ID: 27506652
[TBL] [Abstract][Full Text] [Related]
8. Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats.
Suemaru K; Araki H; Gomita Y
Eur J Pharmacol; 2000 Nov; 408(1):19-23. PubMed ID: 11070179
[TBL] [Abstract][Full Text] [Related]
9. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T
Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
11. Nicotine-induced tail-tremor and drug effects.
Gomita Y; Suemaru K; Furuno K; Araki Y
Pharmacol Biochem Behav; 1989 Dec; 34(4):817-21. PubMed ID: 2576144
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.
Suemaru K; Kawakami Y; Araki H; Gomita Y; Tanizaki Y
Acta Med Okayama; 1998 Feb; 52(1):49-53. PubMed ID: 9548994
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic modulation of nicotine-induced kinetic tremor in mice.
Kunisawa N; Iha HA; Nomura Y; Onishi M; Matsubara N; Shimizu S; Ohno Y
J Pharmacol Sci; 2017 Jun; 134(2):131-138. PubMed ID: 28647281
[TBL] [Abstract][Full Text] [Related]
14. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Zakharova ES; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activity and receptor-binding characteristics of 2 beta-(2'-phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane and its optical isomers.
Gao ZG; Cui WY; Wang L; Liu CG
Arch Int Pharmacodyn Ther; 1996; 331(2):124-35. PubMed ID: 8937624
[TBL] [Abstract][Full Text] [Related]
16. Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor.
Iha HA; Kunisawa N; Shimizu S; Onishi M; Nomura Y; Matsubara N; Iwai C; Ogawa M; Hashimura M; Sato K; Kato M; Ohno Y
Neurotox Res; 2019 Apr; 35(3):575-583. PubMed ID: 30729450
[TBL] [Abstract][Full Text] [Related]
17. (-)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity.
Mulholland PJ; Self RL; Harris BR; Littleton JM; Prendergast MA
Neuroscience; 2004; 125(3):671-82. PubMed ID: 15099681
[TBL] [Abstract][Full Text] [Related]
18. Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats.
Löscher W; Potschka H; Wlaź P; Danysz W; Parsons CG
Eur J Pharmacol; 2003 Apr; 466(1-2):99-111. PubMed ID: 12679146
[TBL] [Abstract][Full Text] [Related]
19. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice.
Zarrindast MR; Homayoun H; Babaie A; Etminani A; Gharib B
Eur J Pharmacol; 2000 Oct; 407(1-2):145-58. PubMed ID: 11050302
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic activity in mice and receptor-binding properties in rats of a series of synthetic tropane derivatives.
Gao ZG; Cui WY; Liu BY; Liu CG; Wang L
J Pharm Pharmacol; 1997 Mar; 49(3):315-8. PubMed ID: 9231353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
